Thursday, July 26, 2018

Gene Therapy - Table of Contents alert Volume 25 Issue 4

If you are unable to see the message below, click here to view.
Gene Therapy


Volume 25, Issue 4

In this issue
Brief Communication
Also new


AAV-mediated NT-3 overexpression protects cochleae against noise-induced synaptopathy

Hengchao Chen, Yazhi Xing, Li Xia, Zhengnong Chen, Shankai Yin et al.

Gene Therapy 2018 25 :251 - 259; March 13, 2018; 10.1038/s41434-018-0012-0


Abstract | Full Text

In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair

Sofia Bougioukli, Osamu Sugiyama, Ram K. Alluri, Robert Yoho, Daniel A. Oakes et al.

Gene Therapy 2018 25 :260 - 268; June 15, 2018; 10.1038/s41434-018-0024-9


Abstract | Full Text

Brief Communication

HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes

Hale M. Tasyurek, Yunus E. Eksi, Ahter D. Sanlioglu, Hasan A. Altunbas, Mustafa K. Balci et al.

Gene Therapy 2018 25 :269 - 283; March 09, 2018; 10.1038/s41434-018-0011-1


Abstract | Full Text

Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor

Zhi-Lei Zhang, Guang-chao Liu, Li Peng, Chong Zhang, Yu-Ming Jia et al.

Gene Therapy 2018 25 :284 - 296; May 25, 2018; 10.1038/s41434-018-0016-9


Abstract | Full Text

Human carbonic anhydrase-8 AAV8 gene therapy inhibits nerve growth factor signaling producing prolonged analgesia and anti-hyperalgesia in mice

Gerald Z. Zhuang, Udita Upadhyay, Xiaoying Tong, Yuan Kang, Diana M. Erasso et al.

Gene Therapy 2018 25 :297 - 311; April 24, 2018; 10.1038/s41434-018-0018-7


Abstract | Full Text

Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma

Chuan Tian, Haixia Wu, Chan Li, Xia Tian, Yong Sun et al.

Gene Therapy 2018 25 :312 - 319; July 04, 2018; 10.1038/s41434-018-0029-4


Abstract | Full Text

Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: